Linked Life Data

10665634

Source:http://linkedlifedata.com/resource/pubmed/id/10665634

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2000-2-16
pubmed:abstractText
The efficacy of citalopram, 20 to 60 mg/day, in relapse prevention in major depression was demonstrated in 6-month placebo-controlled studies. The authors tested the efficacy of citalopram, 40 mg/day, in relapse prevention over a 4-month period and citalopram, 20 mg/day, in recurrence prevention over a 24-month period.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0160-6689
pubmed:author
pubmed:issnType
Print
pubmed:volume
60
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
861-5
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:10665634-Adult, pubmed-meshheading:10665634-Age of Onset, pubmed-meshheading:10665634-Ambulatory Care, pubmed-meshheading:10665634-Citalopram, pubmed-meshheading:10665634-Cost of Illness, pubmed-meshheading:10665634-Depressive Disorder, pubmed-meshheading:10665634-Discriminant Analysis, pubmed-meshheading:10665634-Drug Administration Schedule, pubmed-meshheading:10665634-Female, pubmed-meshheading:10665634-Follow-Up Studies, pubmed-meshheading:10665634-Hospitalization, pubmed-meshheading:10665634-Humans, pubmed-meshheading:10665634-Male, pubmed-meshheading:10665634-Middle Aged, pubmed-meshheading:10665634-Psychiatric Status Rating Scales, pubmed-meshheading:10665634-Recurrence, pubmed-meshheading:10665634-Serotonin Uptake Inhibitors, pubmed-meshheading:10665634-Severity of Illness Index, pubmed-meshheading:10665634-Treatment Outcome
pubmed:year
1999
pubmed:articleTitle
Two-year maintenance treatment with citalopram, 20 mg, in unipolar subjects with high recurrence rate.
pubmed:affiliation
Istituto Scientifico H. San Raffaele, Department of Neuropsychiatric Sciences, School of Medicine, University of Milan, Italy. franchini.linda@hsr.it
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't